BioLineRx (BLRX) Assets (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.77% |
| Sep 30, 2025 | -8.00% |
| Jun 30, 2025 | -0.56% |
| Mar 31, 2025 | 11.83% |
| Dec 31, 2024 | -26.23% |
| Sep 30, 2024 | -18.35% |
| Jun 30, 2024 | 25.19% |
| Mar 31, 2024 | -19.28% |
| Dec 31, 2023 | 20.94% |
| Sep 30, 2023 | -10.32% |
| Jun 30, 2023 | -14.15% |
| Mar 31, 2023 | -10.13% |
| Dec 31, 2022 | -6.48% |
| Sep 30, 2022 | 20.39% |
| Jun 30, 2022 | -9.27% |
| Mar 31, 2022 | -8.13% |
| Dec 31, 2021 | -6.34% |
| Sep 30, 2021 | -4.84% |
| Jun 30, 2021 | 9.25% |
| Mar 31, 2021 | 76.78% |
| Dec 31, 2020 | 2.72% |
| Sep 30, 2020 | -13.12% |
| Jun 30, 2020 | 12.33% |
| Mar 31, 2020 | -11.94% |
| Dec 31, 2019 | -6.39% |
| Sep 30, 2019 | -7.64% |
| Jun 30, 2019 | -8.34% |
| Mar 31, 2019 | 20.20% |
| Dec 31, 2018 | 21.19% |
| Sep 30, 2018 | -11.13% |
| Jun 30, 2018 | -6.89% |
| Mar 31, 2018 | -8.02% |
| Dec 31, 2017 | -7.81% |
| Sep 30, 2017 | 4.88% |
| Jun 30, 2017 | 53.33% |
| Mar 31, 2017 | 5.60% |
| Dec 31, 2016 | -7.90% |
| Sep 30, 2016 | -7.45% |
| Jun 30, 2016 | -6.66% |
| Mar 31, 2016 | -4.60% |
| Dec 31, 2015 | -6.78% |
| Sep 30, 2015 | -5.70% |
| Jun 30, 2015 | -2.54% |
| Mar 31, 2015 | 65.34% |
| Dec 31, 2014 | 17.27% |
| Sep 30, 2014 | -11.73% |
| Jun 30, 2014 | -10.63% |
| Mar 31, 2014 | 95.56% |
| Dec 31, 2013 | -10.39% |
| Sep 30, 2013 | -11.24% |
| Jun 30, 2013 | -18.05% |
| Mar 31, 2013 | 26.22% |